Turmeric effect on subcutaneous insulin-induced amyloid mass: an in vivo study

References

• Aggarwal B, Bhatt I, Ichikawa H, et al. (2007). Curcumin-biological and medicinal properties. Turmeric Genus Curcuma 45:297–368.
   Google Scholar
• Akbik D, Ghadiri M, Chrzanowski W, Rohanizadeh R. (2014). Curcumin as a wound healing agent. Life Sci 116:1–7.
   PubMed Web of Science ®Google Scholar
• Amini R, Yazdanparast R, Bahramikia S. (2013). Apigenin reduces human insulin fibrillation in vitro and protects SK-N-MC cells against insulin amyloids. Int J Biol Macromol 60:334–340.
   PubMed Web of Science ®Google Scholar
• Ansari N, Khodagholi F. (2013). Natural products as promising drug candidates for the treatment of alzheimer’s disease: molecular mechanism aspect. Curr Neuropharmacol 11:414.
   PubMed Web of Science ®Google Scholar
• Asghari G, Mostajeran A, Shebli M. (2010). Curcuminoid and essential oil components of turmeric at different stages of growth cultivated in Iran. Res Pharm Sci 4:55–61.
   Google Scholar
• Bhavanishankar T, Narasimha-Murthy K, Sreenivasa-Murthy V. (1986). Toxicity studies on turmeric (Curcuma longa L.)-Long term toxicity studies in albino rats and monkeys. J Food Sci Technol 23:287–290.
   Web of Science ®Google Scholar
• Bhowmik S, Khanna S, Srivastava K, et al. (2013). An efficient combinatorial synthesis of allocolchicine analogues via a triple cascade reaction and their evaluation as inhibitors of insulin aggregation. ChemMedChem 8:1767–1772.
   PubMed Web of Science ®Google Scholar
• Burgos-Moron E, Calderon-Montano JM, Salvador J, et al. (2010). The dark side of curcumin. Int J Cancer 126:1771–1775.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK. (2004). Turmeric and curcumin: biological actions and medicinal applications. Curr Sci 87:44–53.
   Web of Science ®Google Scholar
• Chinisaz M, Ebrahim-Habibi A, Yaghmaei P, et al. (2014). Generating local amyloidosis in mice by the subcutaneous injection of human insulin amyloid fibrils. Exp Ther Med 8:405–408.
   PubMed Web of Science ®Google Scholar
• Chinisaz M, Larijani B, Ebrahim-Habibi A. (2014). A molecular modeling study on full-length insulin: insight into initial events of amyloid formation. Struct Chem 25:1175–1185.
   Web of Science ®Google Scholar
• Choi TS, Lee JW, Jin KS, Kim HI. (2014). Amyloid fibrillation of insulin under water-limited conditions. Biophys J 107:1939–1949.
   PubMed Web of Science ®Google Scholar
• Cole GM, Teter B, Frautschy SA. (2007). Neuroprotective effects of curcumin. Adv Exp Med Biol 595:197–212.
   PubMed Web of Science ®Google Scholar
• D’Souza A, Theis JD, Vrana JA, Dogan A. (2014). Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration. Amyloid 21:71–75.
   PubMed Web of Science ®Google Scholar
• Hafner‐Bratkovič I, Gašperšič J, Šmid LM, et al. (2008). Curcumin binds to the α‐helical intermediate and to the amyloid form of prion protein–a new mechanism for the inhibition of PrPSc accumulation. J Neurochem 104:1553–1564.
   PubMed Web of Science ®Google Scholar
• Hua QX, Weiss MA. (2004). Mechanism of insulin fibrillation: the structure of insulin under amyloidogenic conditions resembles a protein-folding intermediate. J Biol Chem 279:21449–21460.
   PubMed Web of Science ®Google Scholar
• Kapoor L. (1989). CRC handbook of Ayurvedic medicinal plants. Boca Raton, USA: CRC Press.
   Google Scholar
• Klyubin I, Nicoll AJ, Khalili-Shirazi A, et al. (2014). Peripheral administration of a humanized anti-PrP antibody blocks alzheimer’s disease abeta synaptotoxicity. J Neurosci 34:6140–6145.
   PubMed Web of Science ®Google Scholar
• Lee HH, Choi TS, Lee SJ, et al. (2014a). Supramolecular inhibition of amyloid fibrillation by cucurbit[7]uril. Angew Chem Int Ed Engl 53:7461–7465.
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim Y, Kim HY, et al. (2014b). Aminostyrylbenzofuran directly reduces oligomeric amyloid-β and reverses cognitive deficits in Alzheimer transgenic mice. PLoS One 9:e95733.
   PubMed Web of Science ®Google Scholar
• Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. (2006). Multiple biological activities of curcumin: a short review. Life Sci 78:2081–2087.
   PubMed Web of Science ®Google Scholar
• Maiti P, Manna J, Veleri S, Frautschy S. (2014). Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin. Biomed Res Int 2014:495091.
   PubMed Web of Science ®Google Scholar
• Manafirad A, Farzadfar F, Habibi L, et al. (2014). Is amyloid-β an innocent bystander and marker in Alzheimer’s disease? Is the liability of multivalent cation homeostasis and its influence on amyloid-β function the real mechanism? J Alzheimers Dis 42:69–85.
   PubMed Web of Science ®Google Scholar
• Mishra NK, Joshi KB, Verma S. (2013). Inhibition of human and bovine insulin fibril formation by designed peptide conjugates. Mol Pharm 10:3903–3912.
   PubMed Web of Science ®Google Scholar
• Muzaffar M, Ahmad A. (2011). The mechanism of enhanced insulin amyloid fibril formation by NaCl is better explained by a conformational change model. PLoS One 6:e27906.
   PubMed Web of Science ®Google Scholar
• Noorafshan A, Ashkani-Esfahani S. (2013). A review of therapeutic effects of curcumin. Curr Pharm Des 19:2032–2046.
   PubMed Web of Science ®Google Scholar
• Ono K, Hasegawa K, Naiki H, Yamada M. (2004). Curcumin has potent anti-amyloidogenic effects for Alzheimer’s beta-amyloid fibrils in vitro . J Neurosci Res 75:742–750.
   PubMed Web of Science ®Google Scholar
• Perchiacca JM, Ladiwala AR, Bhattacharya M, Tessier PM. (2012). Structure-based design of conformation- and sequence-specific antibodies against amyloid β. Proc Natl Acad Sci USA 109:84–89.
   PubMed Web of Science ®Google Scholar
• Rabiee A, Ebrahim-Habibi A, Ghasemi A, Nemat-Gorgani M. (2013). How curcumin affords effective protection against amyloid fibrillation in insulin. Food Funct 4:1474–1480.
   PubMed Web of Science ®Google Scholar
• Reid GA, Darvesh S. (2015). Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model. Neuroscience 298:424–435.
   PubMed Web of Science ®Google Scholar
• Ringman JM, Frautschy SA, Cole GM, et al. (2005). A potential role of the curry spice curcumin in Alzheimer’s disease. Curr Alzheimer Res 2:131–136.
   PubMedGoogle Scholar
• Sahoo S, Reeves W, Demay RM. (2003). Amyloid tumor: a clinical and cytomorphologic study. Diagn Cytopathol 28:325–328.
   PubMed Web of Science ®Google Scholar
• Sharma R, Gescher A, Steward W. (2005). Curcumin: the story so far. Eur J Cancer 41:1955–1968.
   PubMed Web of Science ®Google Scholar
• Shikama Y, Kitazawa J, Yagihashi N, et al. (2010). Localized amyloidosis at the site of repeated insulin injection in a diabetic patient. Intern Med 49:397–401.
   PubMed Web of Science ®Google Scholar
• Shim JS, Kim DH, Jung HJ, et al. (2002). Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation. Bioorg Med Chem 10:2987–2992.
   PubMed Web of Science ®Google Scholar
• Sie MP, van der Wiel HE, Smedts FM, de Boer AC. (2010). Human recombinant insulin and amyloidosis: an unexpected association. Neth J Med 68:138–140.
   PubMed Web of Science ®Google Scholar
• Singh PK, Kotia V, Ghosh D, et al. (2012). Curcumin modulates α-synuclein aggregation and toxicity. ACS Chem Neurosci 4:393–407.
   PubMed Web of Science ®Google Scholar
• Sinha S, Lopes DH, Du Z, et al. (2011). Lysine-specific molecular tweezers are broad-spectrum inhibitors of assembly and toxicity of amyloid proteins. J Am Chem Soc 133:16958–16969.
   PubMed Web of Science ®Google Scholar
• Surguchev A, Surguchov A. (2010). Conformational diseases: looking into the eyes. Brain Res Bull 81:12–24.
   PubMed Web of Science ®Google Scholar
• Tayyem RF, Heath DD, Al-Delaimy WK, Rock CL. (2006). Curcumin content of turmeric and curry powders. Nutr Cancer 55:126–131.
   PubMed Web of Science ®Google Scholar
• Valastyan JS, Lindquist S. (2014). Mechanisms of protein-folding diseases at a glance. Dis Model Mech 7:9–14.
   PubMed Web of Science ®Google Scholar
• Wang SSS, Liu KN, Lee WH. (2009). Effect of curcumin on the amyloid fibrillogenesis of hen egg-white lysozyme. Biophys Chem 144:78–87.
   PubMed Web of Science ®Google Scholar
• Yang F, Lim GP, Begum AN, et al. (2005). Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280:5892–5901.
   PubMed Web of Science ®Google Scholar
• Yumlu S, Barany R, Eriksson M, Röcken C. (2009). Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report. Hum Pathol 40:1655–1660.
   PubMed Web of Science ®Google Scholar
• Zanotti G, Cendron L, Folli C, et al. (2013). Structural evidence for native state stabilization of a conformationally labile amyloidogenic transthyretin variant by fibrillogenesis inhibitors. FEBS Lett 587:2325–2331.
   PubMed Web of Science ®Google Scholar